Featured Research

from universities, journals, and other organizations

Considering a three-year medical degree

Date:
September 19, 2013
Source:
NYU Langone Medical Center
Summary:
Educators describe how a three-year medical degree, a radical rethinking of medical education, can increase the number of productive years clinicians and physician scientists spend in the workforce, as well as reduce student debt.

Academic medical centers can help adapt to dramatic changes in health care by offering accelerated study to selected students so that they receive a doctor of medicine degree (MD) in three years rather than the traditional four, according to educational leaders at NYU School of Medicine.

In a Perspective essay in this week's New England Journal of Medicine (NEJM), the educators describe how a three-year medical degree, a radical rethinking of medical education, can increase the number of productive years clinicians and physician scientists spend in the workforce, as well as reduce student debt.

The educators argue that for highly qualified applicants, the three-year degree can be an effective counterbalance to ever more extensive training periods, which now average 10 years for some sub-specialties, without sacrificing quality. NYU School of Medicine began offering a three-year medical degree pathway for selected students this year.

"This article presents a compelling argument that a more effective medical education process is needed," said lead author Steven B. Abramson, MD, vice dean for education, faculty, and academic affairs and chair of the Department of Medicine at NYU School of Medicine. "We are hopeful that this article will encourage continued discussions focused on restructuring medical education to meet the changing health care needs of the population." In addition to Dr. Abramson, authors include Robert I. Grossman, MD, dean and CEO, NYU Langone Medical Center, and Dianna Jacob, RPA, MBA, vice president, Faculty and Academic Affairs.

"A four-year program for all graduates made sense when postgraduate training lasted two or three years. Now, residencies and fellowships routinely extend the postgraduate period to six years or more, which means that many physicians don't enter practice until their early or mid-30s," says Dr. Abramson. "Indeed, data from the American Medical Association show that since 1975, the percentage of physicians under the age of 35 has decreased from 28 percent to 15 percent."

The essay describes how it has been more than 100 years since Abraham Flexner proposed the current model for medical education in North America -- two years of basic science instruction followed by two years of clinical experience. Cutting the average duration of medical training, they note, by approximately 30 percent -- partly by eliminating one year of medical school -- can be accomplished without compromising physicians' competence or the quality of care provided. While the three-year pathway can also reduce student debt by 25 percent, the educators acknowledge the challenges that a three-year pathway poses and say that shortening medical school education is "just one approach to address the need for change in the Post-Flexnerian era."

"We are at a point of inflection whereby alignment of training across the levels of medical education with regulatory standards and our health care delivery system is critical to train physicians and physician scientists who are passionate care providers across specialties," said Robert I. Grossman, MD, dean and CEO at NYU Langone. "In the years ahead, developing a uniform set of milestones and competencies that assess physicians throughout medical school, residency, fellowship and ultimately clinical practice will be a major task for medical educators."


Story Source:

The above story is based on materials provided by NYU Langone Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Steven B. Abramson, Dianna Jacob, Melvin Rosenfeld, Lynn Buckvar-Keltz, Victoria Harnik, Fritz Francois, Rafael Rivera, Mary Ann Hopkins, Marc Triola, Robert I. Grossman. A 3-Year M.D. — Accelerating Careers, Diminishing Debt. New England Journal of Medicine, 2013; 369 (12): 1085 DOI: 10.1056/NEJMp1304681

Cite This Page:

NYU Langone Medical Center. "Considering a three-year medical degree." ScienceDaily. ScienceDaily, 19 September 2013. <www.sciencedaily.com/releases/2013/09/130919140624.htm>.
NYU Langone Medical Center. (2013, September 19). Considering a three-year medical degree. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130919140624.htm
NYU Langone Medical Center. "Considering a three-year medical degree." ScienceDaily. www.sciencedaily.com/releases/2013/09/130919140624.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins